Tumor stroma-associated antigens for anti-cancer immunotherapy Valeska HofmeisterClaudia VetterJürgen C. Becker Review 12 October 2005 Pages: 481 - 494
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes Per thor StratenChristina DahlJürgen C. Becker Original Article 07 July 2005 Pages: 495 - 502
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct Bernd SchlerethCornelia QuadtPatrick A. Baeuerle OriginalPaper 20 July 2005 Pages: 503 - 514
CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice Asim SahaRathindra Nath BaralMalaya Bhattacharya-Chatterjee Original Article 26 July 2005 Pages: 515 - 527
Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients Emma E. FurthJian LiDorothee Herlyn Original Article 21 July 2005 Pages: 528 - 537
Anti-tumor activity of dendritic cells transfected with mRNA for receptor for hyaluronan-mediated motility is mediated by CD4+ T cells Mikiko FukuiKoji UenoYuji Hinoda Original Article 15 July 2005 Pages: 538 - 546
Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity Ulrich T. HackerInes SchildhauerSusan B. S. King Original Article 26 July 2005 Pages: 547 - 557
Tumor skewing of CD34+ cell differentiation from a dendritic cell pathway into endothelial cells M. Rita I. YoungMelinda Cigal Original Article 16 July 2005 Pages: 558 - 568
An intracellular antibody can suppress tumorigenicity in Hepatitis B virus X-expressing cells Young-Hee JinMyung-Hee KwonSun Park Original Article 05 November 2005 Pages: 569 - 578
Spontaneous elicitation of potent antitumor immunity and eradication of established tumors by administration of DNA encoding soluble transforming growth factor-β II receptor without active antigen-sensitization Keiichi KontaniKiichi KajinoKazumasa Ogasawara Original Article 20 July 2005 Pages: 579 - 587
Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors Angelica LoskogChristina NinalgaThomas H. Tötterman Original Article 21 September 2005 Pages: 588 - 597
Lung squamous cell carcinoma and adenocarcinoma cell lines use different mediators to induce comparable phenotypic and functional changes in human monocyte-derived dendritic cells Federico Àvila-MorenoJosé Sullivan López-GonzálezCarmen Sánchez-Torres Original Article 25 August 2005 Pages: 598 - 611
Strategies for immune intervention Niels SchaftJan Dörrie Meeting Report 16 December 2005 Pages: 612 - 622
